Menstrual abnormalities, including menopause, are common among women with food disorders. Due to the abnormalities of menstruation, anxiety was that women with food disorders could be less likely to get pregnant normally.
In a recent study, fertility treatment rates were seen in women with food-related diseases.
In this study, prenatal women were recorded as part of the R Generation Study, which was a future covalent study of the future population located in the Netherlands.
The results were evaluated in those women who reported the history (recent or previous) of Anorexia nervosa (N = 160), Neuropathy nervosa (N = 265), or both (N = 130). Besides eating disorders (n = 1396), women with the history of mental disorders are compared to the group.
The results of these groups were compared with the results of women without any psychiatric disorder (n = 4367).
Fertility treatment spread
Compared to women without psychiatry, there was an increased probability (differential ratio, or 2.3) for reproductive treatment in women with neuropathic illness.
It is interesting that all these women have been infected with schizophrenia in the past but not in the first year of pregnancy.
The rate of fertility treatment for women with anorexia was similar to those women who were not mentally ill. Before the pregnancy BMI does not explain observed results.
Unplanned pregnancies, many births
The prevalence of unplanned pregnancies was higher in all eating disorder groups (32.3% for women with AN, 25.3% for women with BN and 32.3% for women with AN + BN) compared to those with mental disorders 22.3 %).
Similarly, women with other mental disorders reported unplanned pregnancies (29.3%). In the first year of pregnancy, women with AN reported the highest circulation of unplanned pregnancies (55.2%).
The probability of creating twins (Anorexia nervosa, or 2.7, neuropathy, or 2.7, anorexia nervosa or 3.9) in women suffering from any type of eating disorder increases.
Interesting, and one of the few unexpected, the result of this study is that bulimia nervosa, but not anorexia nervosa, is associated with high fertility treatment rate.
An explanation for this discovery may be that women suffering from anorexia nervosa were more likely to express contradictory emotions about pregnancy (5.0 or 5.0) than women with bulimia.
In this study, the reproduction capacity was not seen, but the fertility rate was measured; It is likely that because women with anorexia are more likely to be pregnant, if they are unable to conceive, they may be less likely to get treatment.
The authors raise another possibility for this conclusion. They provide evidence that polycystic ovary syndrome or polycystic ovary syndrome is associated with bulimia and bronchiality during eating, so infertility in women with alopecia can reflect a major diagnosis of PCOS.
This interpretation is in line with this finding that the high rate of infertility was seen in women with a history which is far from Bulimia and there is no weight position.
Overall data assures However, we can not assume that fertility is common in all women with food disorders.
While more population-based studies show that women with the history of food disorders do well, small studies (often with medical derived specimens and possibly focusing on women with more serious or active disease) suggest It is believed that some women may have a fall in fertility and may be able to conceive in general.
This week we will visit Dr. Guests are delighted to receive guest post from Anna Glaser Perineatal Psychiatrist and Mind Body Prognency, a new online resource focused specifically on all issues related to the emotional health of women during their reproductive years at the University of California at San Francisco.
Infertility, which affects many joints, may have many mental health complications such as depression.
The most common treatment drugs can have an effect on the emotional state of women.
Clomiphene (Clomid) and human gland
Cholomyphine is one of the most prescribed medicines in the treatment of infertility. Clomifen is the medicine used to treat ovulation problems, which is a common cause of infertility.
It works by affecting the brain’s gland, leading to the pituitary gland to release the hypothalamus, hormone LH and FSH, which are essential for both the ovulation cycle. Another treatment is the menopause of the gonadal hormone (HMG), which also stimulates ovary function.
The physical side effects of these drugs are well known, for example, hot flashes or symptoms of change in vision, but there is less debate in the emotional side effects. Women taking this medicine described the inability to control or communicate with reality.